Response times average 2-4 hours for non-urgent questions
The onset of one condition can increase the risk of the other, potentially creating a self-reinforcing cycle of disease progression [39, 40]
While these drugs offer impressive results for weight loss and blood sugar control, growing evidence suggests they may come with concerning long-term effects that arent always discussed in the consultation room
Many individuals with well-controlled hypothyroidism on levothyroxine replacement therapy continue to struggle with weight management
Importantly, a meta-analysis of 14 clinical trials evaluating gastrointestinal adverse effects of GLP-1RAs found that long-acting agents had lower rates of nausea and vomiting than short-acting formulations
Consulting with Alfasigma, Amylyx Pharmaceuticals, BioKier, Brightseed Bio, Coloplast, Intercept Pharmaceuticals, Invea Therapeutics, Kallyope (fee to Mayo Clinic), Medpace, Monteresearch S.r.L., Neurogastrx, Renexxion, SKYE Bioscience, Sumitomo Pharmaceuticals, Synlogic, and McDermott Will & Emery LLP
